HORMONAL CONTRACEPTION: PRESENT AND FUTURE

被引:10
|
作者
Benagiano, Giuseppe [1 ]
Bastianelli, Carlo [1 ]
Farris, Manuela [1 ]
机构
[1] Univ Roma La Sapienza, Dept Obstet & Gynecol, I-00100 Rome, Italy
关键词
D O I
10.1358/dot.2008.44.12.1299292
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The original form of hormonal contraception ("the Pill") has developed into a variety of modalities administered through different routes: oral, intramuscular, subcutaneous, transdermal, intrauterine or intravaginal, and intranasal (abandoned). At present, two separate methods of hormonal contraception exist; one is used to prevent fertilization and the other to prevent pregnancy. From a pharmacological point of view, hormonal methods utilize either a combination of estrogen and progestin or progestin alone. Today all combined methods contain ethynylestradiol, and over the years there has been a substantial reduction in its dosage from almost 80 mu g to as low as 15 mu g. On the other hand, a variety of progestins are currently utilized that belong to two main chemical families: derivatives of progesterone and derivatives of 19-nortestosterone or gonane. These compounds, developed over a period of 50 years, can be distinguished in four successive "generations". Recent developments include new oral regimens intended to change the 7-day medication-free interval and new commercial preparations; the latter utilize the progestins drospirenone and dienogest. In addition, an oral contraceptive containing chlormadinone has also been marketed. Besides the oral route, contraceptive systems exist or are under development that employ the intramuscular, transdermal and intravaginal routes; they deliver both an estrogen and a progestin. Several patches and vaginal rings are also marketed. A variety of long-acting methods delivering only a progestin are also available. They use the subcutaneous route or are released from an intrauterine system, both of which provide optimal contraceptive protection and, depending on the system, can last up to 5 years (and probably more). Finally, progestin-releasing vaginal rings are under investigation. The second type of hormonal contraception, called "emergency contraception", utilizes progestins and antiprogestins and to be effective should be taken as soon as possible after unprotected intercourse.
引用
收藏
页码:905 / 923
页数:19
相关论文
共 50 条
  • [41] Hormonal contraception and HIV
    vanderLinde, I
    [J]. SOUTH AFRICAN MEDICAL JOURNAL, 1996, 86 (10): : 1231 - 1232
  • [42] HORMONAL CONTRACEPTION AND DISEASE
    BASDEVANT, A
    [J]. REVUE DE MEDECINE, 1981, 22 (04): : 201 - 205
  • [43] Depression and hormonal contraception
    Freeman, MP
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (06): : 671 - 672
  • [44] Hormonal intervention in breast cancer - Past, present, and future
    Osborne, MP
    [J]. BASIS FOR CANCER MANAGEMENT, 1996, 784 : 427 - 432
  • [45] Hormonal treatment of endometrial cancer: past, present and future
    Podczaski, E
    Mortel, R
    [J]. BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY, 2001, 15 (03): : 469 - 489
  • [46] HORMONAL ASSAY METHODOLOGY - PRESENT AND FUTURE-PROSPECTS
    ALBERTSON, BD
    [J]. CLINICAL OBSTETRICS AND GYNECOLOGY, 1990, 33 (03): : 591 - 610
  • [47] Intrauterine hormonal contraception
    Roemer, T.
    Buehling, K. J.
    [J]. GYNAKOLOGISCHE ENDOKRINOLOGIE, 2013, 11 (03): : 188 - 196
  • [48] HORMONAL CONTRACEPTION AND THE BREAST
    CABY, J
    KUTTENN, F
    [J]. REVUE DE MEDECINE, 1981, 22 (14): : 817 - 821
  • [49] Male hormonal contraception
    Oxynos, C
    Wu, FCW
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 14 (03) : 473 - 487
  • [50] Initiating Hormonal Contraception
    Lesnewski, Ruth
    [J]. AMERICAN FAMILY PHYSICIAN, 2021, 103 (05) : 291 - 300